nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—Ulcer—Spironolactone—dilated cardiomyopathy	0.0395	0.0445	CcSEcCtD
Pentazocine—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.0244	0.0275	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0244	0.0275	CcSEcCtD
Pentazocine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0232	0.0261	CcSEcCtD
Pentazocine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0195	0.022	CcSEcCtD
Pentazocine—Lightheadedness—Furosemide—dilated cardiomyopathy	0.0182	0.0205	CcSEcCtD
Pentazocine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.0177	0.02	CcSEcCtD
Pentazocine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0157	0.0177	CcSEcCtD
Pentazocine—Irritability—Furosemide—dilated cardiomyopathy	0.0141	0.0159	CcSEcCtD
Pentazocine—Urinary retention—Furosemide—dilated cardiomyopathy	0.014	0.0158	CcSEcCtD
Pentazocine—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.0136	0.0154	CcSEcCtD
Pentazocine—Confusional state—Spironolactone—dilated cardiomyopathy	0.0134	0.0151	CcSEcCtD
Pentazocine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0133	0.015	CcSEcCtD
Pentazocine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.0133	0.015	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.0133	0.015	CcSEcCtD
Pentazocine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.0127	0.0143	CcSEcCtD
Pentazocine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.0126	0.0142	CcSEcCtD
Pentazocine—Somnolence—Spironolactone—dilated cardiomyopathy	0.0118	0.0133	CcSEcCtD
Pentazocine—Diplopia—Lisinopril—dilated cardiomyopathy	0.0111	0.0125	CcSEcCtD
Pentazocine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.011	0.0124	CcSEcCtD
Pentazocine—Sweating—Furosemide—dilated cardiomyopathy	0.0109	0.0123	CcSEcCtD
Pentazocine—Face oedema—Lisinopril—dilated cardiomyopathy	0.0107	0.012	CcSEcCtD
Pentazocine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.0106	0.0119	CcSEcCtD
Pentazocine—Irritability—Lisinopril—dilated cardiomyopathy	0.0106	0.0119	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00996	0.0112	CcSEcCtD
Pentazocine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00996	0.0112	CcSEcCtD
Pentazocine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00983	0.0111	CcSEcCtD
Pentazocine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00981	0.0111	CcSEcCtD
Pentazocine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00964	0.0109	CcSEcCtD
Pentazocine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00951	0.0107	CcSEcCtD
Pentazocine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00947	0.0107	CcSEcCtD
Pentazocine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00942	0.0106	CcSEcCtD
Pentazocine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00931	0.0105	CcSEcCtD
Pentazocine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00911	0.0103	CcSEcCtD
Pentazocine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00881	0.00992	CcSEcCtD
Pentazocine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00869	0.00979	CcSEcCtD
Pentazocine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00854	0.00962	CcSEcCtD
Pentazocine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00847	0.00954	CcSEcCtD
Pentazocine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00839	0.00945	CcSEcCtD
Pentazocine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00837	0.00943	CcSEcCtD
Pentazocine—Headache—Spironolactone—dilated cardiomyopathy	0.00834	0.0094	CcSEcCtD
Pentazocine—Sweating—Lisinopril—dilated cardiomyopathy	0.00817	0.00921	CcSEcCtD
Pentazocine—Agitation—Furosemide—dilated cardiomyopathy	0.00816	0.00919	CcSEcCtD
Pentazocine—Vertigo—Furosemide—dilated cardiomyopathy	0.00798	0.00899	CcSEcCtD
Pentazocine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00796	0.00896	CcSEcCtD
Pentazocine—Nausea—Spironolactone—dilated cardiomyopathy	0.00791	0.00891	CcSEcCtD
Pentazocine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00761	0.00858	CcSEcCtD
Pentazocine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00739	0.00833	CcSEcCtD
Pentazocine—Confusional state—Furosemide—dilated cardiomyopathy	0.00731	0.00823	CcSEcCtD
Pentazocine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00725	0.00816	CcSEcCtD
Pentazocine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00724	0.00815	CcSEcCtD
Pentazocine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00714	0.00804	CcSEcCtD
Pentazocine—Shock—Furosemide—dilated cardiomyopathy	0.00713	0.00803	CcSEcCtD
Pentazocine—Flushing—Lisinopril—dilated cardiomyopathy	0.0071	0.008	CcSEcCtD
Pentazocine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00701	0.00789	CcSEcCtD
Pentazocine—Anorexia—Furosemide—dilated cardiomyopathy	0.00691	0.00778	CcSEcCtD
Pentazocine—Chills—Lisinopril—dilated cardiomyopathy	0.00687	0.00774	CcSEcCtD
Pentazocine—Hypotension—Furosemide—dilated cardiomyopathy	0.00677	0.00763	CcSEcCtD
Pentazocine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00652	0.00735	CcSEcCtD
Pentazocine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00651	0.00733	CcSEcCtD
Pentazocine—Somnolence—Furosemide—dilated cardiomyopathy	0.00644	0.00726	CcSEcCtD
Pentazocine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00641	0.00722	CcSEcCtD
Pentazocine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.0063	0.0071	CcSEcCtD
Pentazocine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00628	0.00707	CcSEcCtD
Pentazocine—Tremor—Lisinopril—dilated cardiomyopathy	0.00624	0.00703	CcSEcCtD
Pentazocine—Constipation—Furosemide—dilated cardiomyopathy	0.0062	0.00698	CcSEcCtD
Pentazocine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00599	0.00674	CcSEcCtD
Pentazocine—Syncope—Lisinopril—dilated cardiomyopathy	0.00597	0.00673	CcSEcCtD
Pentazocine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00597	0.00673	CcSEcCtD
Pentazocine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00586	0.0066	CcSEcCtD
Pentazocine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00555	0.00625	CcSEcCtD
Pentazocine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00548	0.00618	CcSEcCtD
Pentazocine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00544	0.00612	CcSEcCtD
Pentazocine—Shock—Lisinopril—dilated cardiomyopathy	0.00535	0.00603	CcSEcCtD
Pentazocine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00534	0.00601	CcSEcCtD
Pentazocine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00531	0.00598	CcSEcCtD
Pentazocine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00526	0.00592	CcSEcCtD
Pentazocine—Asthenia—Furosemide—dilated cardiomyopathy	0.0052	0.00586	CcSEcCtD
Pentazocine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00518	0.00584	CcSEcCtD
Pentazocine—Pruritus—Furosemide—dilated cardiomyopathy	0.00513	0.00578	CcSEcCtD
Pentazocine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00508	0.00572	CcSEcCtD
Pentazocine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00496	0.00559	CcSEcCtD
Pentazocine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00492	0.00554	CcSEcCtD
Pentazocine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00488	0.0055	CcSEcCtD
Pentazocine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00485	0.00546	CcSEcCtD
Pentazocine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00483	0.00544	CcSEcCtD
Pentazocine—Dizziness—Furosemide—dilated cardiomyopathy	0.00479	0.0054	CcSEcCtD
Pentazocine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00473	0.00532	CcSEcCtD
Pentazocine—Constipation—Lisinopril—dilated cardiomyopathy	0.00465	0.00524	CcSEcCtD
Pentazocine—Vomiting—Furosemide—dilated cardiomyopathy	0.00461	0.00519	CcSEcCtD
Pentazocine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00456	0.00514	CcSEcCtD
Pentazocine—Headache—Furosemide—dilated cardiomyopathy	0.00454	0.00511	CcSEcCtD
Pentazocine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00448	0.00505	CcSEcCtD
Pentazocine—Nausea—Furosemide—dilated cardiomyopathy	0.0043	0.00485	CcSEcCtD
Pentazocine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00401	0.00451	CcSEcCtD
Pentazocine—Asthenia—Lisinopril—dilated cardiomyopathy	0.0039	0.00439	CcSEcCtD
Pentazocine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00385	0.00433	CcSEcCtD
Pentazocine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00372	0.00419	CcSEcCtD
Pentazocine—Dizziness—Lisinopril—dilated cardiomyopathy	0.0036	0.00405	CcSEcCtD
Pentazocine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00346	0.00389	CcSEcCtD
Pentazocine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00343	0.00386	CcSEcCtD
Pentazocine—Headache—Lisinopril—dilated cardiomyopathy	0.00341	0.00384	CcSEcCtD
Pentazocine—EBP—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00339	0.0302	CbGpPWpGaD
Pentazocine—Nausea—Lisinopril—dilated cardiomyopathy	0.00323	0.00364	CcSEcCtD
Pentazocine—EBP—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00318	0.0284	CbGpPWpGaD
Pentazocine—OPRD1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00253	0.0225	CbGpPWpGaD
Pentazocine—OPRD1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00235	0.021	CbGpPWpGaD
Pentazocine—OPRK1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00222	0.0198	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00222	0.0198	CbGpPWpGaD
Pentazocine—OPRK1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00206	0.0184	CbGpPWpGaD
Pentazocine—OPRD1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00195	0.0173	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00195	0.0173	CbGpPWpGaD
Pentazocine—OPRM1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00188	0.0167	CbGpPWpGaD
Pentazocine—OPRM1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00174	0.0155	CbGpPWpGaD
Pentazocine—OPRK1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00171	0.0152	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00164	0.0146	CbGpPWpGaD
Pentazocine—EBP—Metabolism—ANKRD1—dilated cardiomyopathy	0.00151	0.0134	CbGpPWpGaD
Pentazocine—OPRM1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00144	0.0128	CbGpPWpGaD
Pentazocine—EBP—Metabolism—TAZ—dilated cardiomyopathy	0.00142	0.0126	CbGpPWpGaD
Pentazocine—OPRM1—IL4-mediated signaling events—IL10—dilated cardiomyopathy	0.00139	0.0124	CbGpPWpGaD
Pentazocine—OPRM1—IL4-mediated signaling events—RPS6KB1—dilated cardiomyopathy	0.00135	0.0121	CbGpPWpGaD
Pentazocine—EBP—Metabolism—SDHA—dilated cardiomyopathy	0.00128	0.0114	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00119	0.0106	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00119	0.0106	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00111	0.00985	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00104	0.0093	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00104	0.0093	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.001	0.00894	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.001	0.00894	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00097	0.00864	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000933	0.00831	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000932	0.0083	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—FAS—dilated cardiomyopathy	0.000926	0.00825	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000915	0.00815	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000882	0.00786	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000882	0.00786	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00088	0.00784	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00088	0.00784	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000866	0.00772	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000839	0.00747	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00082	0.0073	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000819	0.00729	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000817	0.00728	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000803	0.00715	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000798	0.00711	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000798	0.00711	CbGpPWpGaD
Pentazocine—EBP—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000782	0.00697	CbGpPWpGaD
Pentazocine—EBP—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000762	0.00679	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00076	0.00677	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000744	0.00663	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000744	0.00663	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000742	0.00661	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000736	0.00655	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000719	0.0064	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000717	0.00638	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0007	0.00623	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0007	0.00623	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000692	0.00616	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000691	0.00615	CbGpPWpGaD
Pentazocine—EBP—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000686	0.00611	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00068	0.00605	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000678	0.00604	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000651	0.0058	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000644	0.00574	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000642	0.00572	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00063	0.00561	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000628	0.0056	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000622	0.00554	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000614	0.00547	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000608	0.00541	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000608	0.00541	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.000602	0.00536	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000596	0.00531	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000592	0.00527	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000592	0.00527	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000582	0.00519	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000565	0.00503	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000565	0.00503	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00055	0.0049	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000547	0.00488	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000543	0.00484	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000538	0.00479	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000533	0.00475	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000533	0.00475	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000533	0.00474	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000531	0.00473	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000511	0.00455	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000504	0.00449	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000496	0.00441	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00048	0.00427	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000477	0.00425	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000476	0.00424	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000467	0.00416	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000455	0.00405	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000451	0.00401	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000451	0.00401	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000443	0.00395	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000432	0.00385	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000432	0.00384	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000419	0.00373	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00041	0.00365	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000406	0.00361	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000403	0.00359	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000389	0.00346	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000379	0.00337	CbGpPWpGaD
Pentazocine—EBP—Metabolism—GPX1—dilated cardiomyopathy	0.000348	0.0031	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000346	0.00309	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000344	0.00306	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000344	0.00306	CbGpPWpGaD
Pentazocine—EBP—Metabolism—CD36—dilated cardiomyopathy	0.000339	0.00302	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000329	0.00293	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000329	0.00293	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00032	0.00285	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000319	0.00284	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000312	0.00278	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000312	0.00278	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000309	0.00276	CbGpPWpGaD
Pentazocine—EBP—Metabolism—AGT—dilated cardiomyopathy	0.000305	0.00272	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000301	0.00268	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000301	0.00268	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00029	0.00258	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000288	0.00257	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000281	0.0025	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00028	0.00249	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000274	0.00244	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000274	0.00244	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000271	0.00242	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000264	0.00235	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000255	0.00227	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000255	0.00227	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000254	0.00227	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000251	0.00223	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000246	0.00219	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000244	0.00217	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00024	0.00214	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000237	0.00211	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000232	0.00206	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000231	0.00206	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000231	0.00206	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000229	0.00204	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000228	0.00203	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00022	0.00196	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000215	0.00191	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00021	0.00187	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000208	0.00185	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000208	0.00185	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.0002	0.00178	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000196	0.00174	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000195	0.00173	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000186	0.00166	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000186	0.00165	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000184	0.00164	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000184	0.00164	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000182	0.00162	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000178	0.00158	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000177	0.00157	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000171	0.00153	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000171	0.00152	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000169	0.0015	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000169	0.0015	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000166	0.00148	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000163	0.00145	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000162	0.00144	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000162	0.00144	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000155	0.00138	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000154	0.00137	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00015	0.00134	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000148	0.00132	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000146	0.0013	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000144	0.00128	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000142	0.00126	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000138	0.00123	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000137	0.00122	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000137	0.00122	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000134	0.0012	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000131	0.00117	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000127	0.00113	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000125	0.00111	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000124	0.00111	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000123	0.0011	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000118	0.00105	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000117	0.00104	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000116	0.00103	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000105	0.000935	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000104	0.00093	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000103	0.000915	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000101	0.000902	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AGT—dilated cardiomyopathy	9.97e-05	0.000888	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.96e-05	0.000887	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	9.15e-05	0.000815	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	8.74e-05	0.000779	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.68e-05	0.000773	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.56e-05	0.000763	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.03e-05	0.000716	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	7.74e-05	0.000689	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AGT—dilated cardiomyopathy	7.39e-05	0.000658	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.05e-05	0.000627	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	6.92e-05	0.000616	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	6.07e-05	0.000541	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.95e-05	0.00053	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	5.13e-05	0.000457	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.75e-05	0.000423	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.16e-05	0.000371	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	3.52e-05	0.000313	CbGpPWpGaD
